Vygon UK Announced as New distributor for NICE-approved, NHSE-endorsed catheter securement device, SecurAcath® By admin|2024-03-14T20:44:18+00:00September 20th, 2023|News|0 Comments Read More
SecurAcath® Receives Innovative Technology Contract from Vizient By admin|2024-03-14T20:44:55+00:00April 4th, 2022|News|0 Comments Read More
Interrad Medical and Eloquest Healthcare Partner to Expand U.S. Sales of SecurAcath By admin|2024-03-14T20:45:37+00:00February 23rd, 2022|News|0 Comments Read More
SecurAcath® Receives Boost from New NHS MedTech Funding Mandate By admin|2024-03-14T20:46:08+00:00March 10th, 2021|News|0 Comments Read More
SecurAcath® Featured Prominently in New Infusion Therapy Standards By admin|2024-03-14T20:46:44+00:00January 26th, 2021|News|0 Comments Read More
SecurAcath® Significantly Reduces Catheter-Related Infection Risk By Judy|2024-03-14T20:47:20+00:00June 24th, 2020|News|0 Comments Read More
Italian Vascular Access Group Recommends Use of SecurAcath on COVID-19 Patients By Judy|2020-04-14T13:53:36+00:00April 14th, 2020|News|0 Comments Read More
SecurAcath Study of Over 2000 Patients Shows Major Cost Savings Compared to Adhesives By Judy|2019-07-23T19:18:08+00:00July 16th, 2019|News|0 Comments Read More
Interrad Medical Announces Agreement with Vygon to Distribute SecurAcath in France By Judy|2018-12-04T16:31:51+00:00October 15th, 2018|News|0 Comments Read More
New Clinical Data Shows Decreased Catheter-Related Infection Risk with Use of SecurAcath By Judy|2018-12-04T16:31:31+00:00September 26th, 2018|News|0 Comments Read More